San Mateo, CA, United States of America

Yi-Chun Hsiao


Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Yi-Chun Hsiao: A Leading Innovator in Neurobiology**

Introduction

Yi-Chun Hsiao is an accomplished inventor based in San Mateo, California, renowned for his contributions to the field of neurobiology. With a total of seven patents, Hsiao is making significant strides in developing innovative therapies targeting neurodegenerative diseases and other conditions affected by immune system activities.

Latest Patents

Hsaio's latest patents include groundbreaking work on **Agonists of TREM2**. This application reveals certain antibodies specifically designed to bind to human TREM2 (triggering receptor expressed on myeloid cells 2). These antibodies serve as TREM2 agonists, selectively interacting with the stalk region of intact human TREM2 while avoiding soluble TREM2—whose cleavage occurs between residues H157 and S158. The antibodies have demonstrated the capability to bind with high specificity and potency, ranging from 10 nM to as low as 1-10 pM, while also showing promise in enhancing the survival of human microglia cells and boosting Aβ plaque formation. Moreover, they inhibit the shedding of soluble TREM2 in various models, which could lead to neuroprotective activities beneficial in treating neurodegenerative disorders.

Another significant patent under Hsiao's name involves **Anti-interleukin-33 antibodies and uses thereof**. This invention provides antibodies targeting interleukin-33 (IL-33) and outlines the methods for their application, showcasing the potential for therapeutic interventions in conditions driven by immune responses.

Career Highlights

Hsiao is currently affiliated with Genentech, Inc., where he leverages his expertise to drive innovations in therapeutic research. His contributions have positioned him as a vital figure in exploring the nuances of immune responses related to neurodegeneration.

Collaborations

Within his professional landscape, Yi-Chun Hsiao collaborates with notable colleagues including Dhaya Seshasayee and Feny Gunawan. These collaborations reflect the combined efforts of talented individuals dedicated to advancing scientific breakthroughs and addressing significant medical challenges.

Conclusion

Yi-Chun Hsiao exemplifies the spirit of innovation in the realm of neurobiology. Through his pioneering patents and collaborations, he is at the forefront of developing new therapies that may transform the future of treatment for neurodegenerative diseases and enhance our understanding of immune functions. His ongoing work not only represents individual excellence but also embodies the power of teamwork and innovation in scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…